To put a bit more commentary to this interview here are the key points I got out of it:
- it takes a bloody long time to get a drug/ therapy to market…..nothing new here
- raising money be it $1.00 or $1 million is difficult and spending it wisely is important
- there are no short cuts to the regulatory process; it takes time; it takes money and you have do it right
- trial design is extremely important and not all trials are comparable ; opthea phase II trial was one of the largest; it gave a lot of data and helped with design of phase III
- data is everything
- no point having a successful drug if you don’t have physicians who want to use it; you need to spend money on educating medicos and getting opinion leaders in place early
- there is a lot of time where a company has nothing news worthy to report but there is lots happening behind the scenes
- you have to have investors that understand and are are confident in what you are doing and are there for the the whole journey
- The team and having the right people on board at the right time is very important. Megan pointed out that while she had never commercialised a drug she had people on her board as well as consultants who had.
- Forums
- ASX - By Stock
- OPT
- Ann: Opthea Announces MST Conference call with Jason Slakter MD
Ann: Opthea Announces MST Conference call with Jason Slakter MD, page-9
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
|
|||||
Last
47.5¢ |
Change
-0.020(4.04%) |
Mkt cap ! $584.7M |
Open | High | Low | Value | Volume |
49.5¢ | 50.8¢ | 47.5¢ | $4.304M | 9.050M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 29597 | 47.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.5¢ | 15044 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 27497 | 0.475 |
4 | 69173 | 0.470 |
1 | 15044 | 0.465 |
1 | 18645 | 0.460 |
3 | 20931 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.485 | 15044 | 2 |
0.490 | 15044 | 1 |
0.500 | 1540 | 1 |
0.505 | 1970 | 1 |
0.510 | 66230 | 3 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online